Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

ClinicalTrials.gov ID: NCT06562192

Public ClinicalTrials.gov record NCT06562192. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 30, 2026, 11:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase I Open-label, Multi-center Study to Evaluate the Safety, Tolerability, Dosimetry, and Preliminary Activity of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

Study identification

NCT ID: NCT06562192
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: Novartis Pharmaceuticals; Industry
Enrollment: 162 participants

Conditions and interventions

Conditions

Interventions

[177Lu]Lu-NNS309 Drug
[68Ga]Ga-NNS309 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 100 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 14, 2024
Primary completion: Jan 14, 2031
Completion: Jan 15, 2031
Last update posted: Apr 23, 2026

2024 – 2031

United States locations

U.S. sites: 9
U.S. states: 8
U.S. cities: 9

Facility	City	State	ZIP	Site status
Uni of Alabama at Birmingham	Birmingham	Alabama	35249	Recruiting
University of California LA	Los Angeles	California	90095	Recruiting
Stanford University Medical Center	Palo Alto	California	94304	Recruiting
Mayo Clinic Jacksonville	Jacksonville	Florida	32224	Recruiting
Massachusetts General Hospital	Boston	Massachusetts	02114	Recruiting
BAMF Health	Grand Rapids	Michigan	49503	Recruiting
Mayo Clinic Rochester	Rochester	Minnesota	55905	Recruiting
Uni Of TX MD Anderson Cancer Cntr	Houston	Texas	77030	Recruiting
University Of Washington	Seattle	Washington	98109	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06562192, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 23, 2026 · Synced Apr 30, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06562192 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →